NAK INHIBITORS FOR COMBATING DENGUE, EBOLA, COVID-19, AND OTHER EMERGING VIRAL INFECTIONS

$1,638,687FY2021Defense Health AgencyDOD

The Leland Stanford Junior University

Investigators